Invesco Nasdaq Biotechnology ETF (IBBQ)
Net flows (30d): +$11.2M Estimated from creation/redemption of shares outstanding
IBBQ Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -5.32% | ▼ -4.69% |
| 3M | ▲ +16.27% | ▲ +17.32% |
| 6M | ▲ +16.27% | ▲ +17.32% |
| YTD | ▲ +21.04% | ▲ +22.13% |
| 1Y | ▲ +37.04% | ▲ +38.72% |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +49.56% | ▲ +54.13% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 256 holdings
| Issuer | Ticker | Weight % | Market value | Shares | CUSIP | Units/share | Type | Currency |
|---|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | GILD | 8.24 | ≈$8.7M | 59,068 | 375558103 | 0.01923 | EQUITY | USD |
| Amgen Inc | AMGN | 7.75 | ≈$8.2M | 20,117 | 031162100 | 0.006546 | EQUITY | USD |
| Vertex Pharmaceuticals Inc | VRTX | 7.61 | ≈$8.0M | 15,881 | 92532F100 | 0.005168 | EQUITY | USD |
| Moderna Inc | MRNA | 5.05 | ≈$5.3M | 28,250 | 60770K107 | 0.009196 | EQUITY | USD |
| Regeneron Pharmaceuticals Inc | REGN | 4.97 | ≈$5.3M | 7,153 | 75886F107 | 0.00233 | EQUITY | USD |
| Revolution Medicines Inc | RVMD | 2.95 | ≈$3.1M | 15,163 | 76155X100 | 0.00494 | EQUITY | USD |
| Illumina Inc | ILMN | 2.69 | ≈$2.8M | 10,685 | 452327109 | 0.003478 | EQUITY | USD |
| Biogen Inc | BIIB | 2.20 | ≈$2.3M | 10,457 | 09062X103 | 0.003404 | EQUITY | USD |
| Alnylam Pharmaceuticals Inc | ALNY | 2.07 | ≈$2.2M | 9,468 | 02043Q107 | 0.003082 | EQUITY | USD |
| Royalty Pharma PLC | RPRX | 1.72 | ≈$1.8M | 31,502 | G7709Q104 | 0.01026 | EQUITY | USD |
| Roivant Sciences Ltd | ROIV | 1.72 | ≈$1.8M | 51,097 | G76279101 | 0.01664 | EQUITY | USD |
| Argenx SE | ARGX | 1.71 | ≈$1.8M | 1,926 | 04016X101 | 0.0006274 | ADR | USD |
| United Therapeutics Corp | UTHR | 1.64 | ≈$1.7M | 3,037 | 91307C102 | 0.0009893 | EQUITY | USD |
| Incyte Corp | INCY | 1.59 | ≈$1.7M | 14,343 | 45337C102 | 0.004669 | EQUITY | USD |
| Insmed Inc | INSM | 1.59 | ≈$1.7M | 15,452 | 457669307 | 0.005034 | EQUITY | USD |
| Guardant Health Inc | GH | 1.57 | ≈$1.7M | 9,493 | 40131M109 | 0.003091 | EQUITY | USD |
| Viatris Inc | VTRS | 1.34 | ≈$1.4M | 81,239 | 92556V106 | 0.02646 | EQUITY | USD |
| Medpace Holdings Inc | MEDP | 1.11 | ≈$1.2M | 1,969 | 58506Q109 | 0.0006414 | EQUITY | USD |
| Jazz Pharmaceuticals PLC | JAZZ | 1.01 | ≈$1.1M | 4,592 | G50871105 | 0.001495 | EQUITY | USD |
| Exelixis Inc | EXEL | 0.96 | ≈$1.0M | 17,520 | 30161Q104 | 0.005708 | EQUITY | USD |
| Neurocrine Biosciences Inc | NBIX | 0.96 | ≈$1.0M | 7,190 | 64125C109 | 0.002344 | EQUITY | USD |
| Ascendis Pharma A/S | ASND | 0.94 | ≈$989K | 4,352 | K08588103 | 0.001418 | EQUITY | USD |
| Tempus AI Inc | TEM | 0.90 | ≈$949K | 12,405 | 88023B103 | 0.00404 | EQUITY | USD |
| Bridgebio Pharma Inc | BBIO | 0.90 | ≈$948K | 14,173 | 10806X102 | 0.004618 | EQUITY | USD |
| Summit Therapeutics Inc | SMMT | 0.89 | ≈$942K | 56,422 | 86627T108 | 0.01838 | EQUITY | USD |
| BeOne Medicines Ltd | ONC | 0.86 | ≈$909K | 2,534 | 07725L102 | 0.0008254 | ADR | USD |
| Twist Bioscience Corp | TWST | 0.83 | ≈$882K | 4,688 | 90184D100 | 0.001528 | EQUITY | USD |
| Halozyme Therapeutics Inc | HALO | 0.81 | ≈$858K | 8,022 | 40637H109 | 0.002614 | EQUITY | USD |
| Madrigal Pharmaceuticals Inc | MDGL | 0.77 | ≈$815K | 1,631 | 558868105 | 0.0005313 | EQUITY | USD |
| BioMarin Pharmaceutical Inc | BMRN | 0.76 | ≈$801K | 13,701 | 09061G101 | 0.004459 | EQUITY | USD |
| BioNTech SE | BNTX | 0.75 | ≈$794K | 8,198 | 09075V102 | 0.00267 | ADR | USD |
| 10X Genomics Inc | TXG | 0.71 | ≈$755K | 8,510 | 88025U109 | 0.002772 | EQUITY | USD |
| ImmunityBio Inc | IBRX | 0.66 | ≈$695K | 74,882 | 45256X103 | 0.02439 | EQUITY | USD |
| Krystal Biotech Inc | KRYS | 0.65 | ≈$682K | 2,098 | 501147102 | 0.0006834 | EQUITY | USD |
| Axsome Therapeutics Inc | AXSM | 0.64 | ≈$674K | 3,702 | 05464T104 | 0.001206 | EQUITY | USD |
| Arrowhead Pharmaceuticals Inc | ARWR | 0.61 | ≈$648K | 10,003 | 04280A100 | 0.003258 | EQUITY | USD |
| Kymera Therapeutics Inc | KYMR | 0.61 | ≈$647K | 5,875 | 501575104 | 0.001915 | EQUITY | USD |
| Cytokinetics Inc | CYTK | 0.61 | ≈$645K | 9,831 | 23282W605 | 0.003203 | EQUITY | USD |
| Protagonist Therapeutics Inc | PTGX | 0.60 | ≈$637K | 4,579 | 74366E102 | 0.001491 | EQUITY | USD |
| Sanofi SA | SNY | 0.59 | ≈$620K | 15,256 | 80105N105 | 0.004966 | ADR | USD |
| Vaxcyte Inc | PCVX | 0.56 | ≈$589K | 10,515 | 92243G108 | 0.003428 | EQUITY | USD |
| Caris Life Sciences Inc | CAI | 0.54 | ≈$566K | 19,982 | 142152107 | 0.00651 | EQUITY | USD |
| Praxis Precision Medicines Inc | PRAX | 0.53 | ≈$565K | 1,969 | 74006W207 | 0.0006414 | EQUITY | USD |
| Spyre Therapeutics Inc | SYRE | 0.53 | ≈$560K | 6,226 | 00773J202 | 0.002028 | EQUITY | USD |
| Ionis Pharmaceuticals Inc | IONS | 0.49 | ≈$517K | 11,744 | 462222100 | 0.003828 | EQUITY | USD |
| Amneal Pharmaceuticals Inc | AMRX | 0.47 | ≈$494K | 24,624 | 03168L105 | 0.008023 | EQUITY | USD |
| Immunovant Inc | IMVT | 0.47 | ≈$492K | 14,619 | 45258J102 | 0.004758 | EQUITY | USD |
| Alkermes PLC | ALKS | 0.46 | ≈$481K | 11,872 | G01767105 | 0.003864 | EQUITY | USD |
| Iovance Biotherapeutics Inc | IOVA | 0.43 | ≈$456K | 32,023 | 462260100 | 0.01043 | EQUITY | USD |
| Rhythm Pharmaceuticals Inc | RYTM | 0.43 | ≈$455K | 4,873 | 76243J105 | 0.001586 | EQUITY | USD |
Market value is estimated from each holding's weight and the fund's net assets. Weight and shares are as reported by the fund.
Sector breakdown
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Sept. 30, 2026 | Trimmed | 2200963D — OmniAb Inc | Units/share: 0.00004266 → 0.00004072 (-4.6%) |
| Sept. 30, 2026 | Trimmed | 2200964D — OmniAb Inc | Units/share: 0.00004266 → 0.00004072 (-4.6%) |
| Sept. 30, 2026 | New | 2298455D — Coherus Oncology Inc | New position — 0.003563 units/share |
| Sept. 30, 2026 | Trimmed | 2324462D — Cartesian Therapeutics Inc | Units/share: 0.0008986 → 0.0008577 (-4.6%) |
| Sept. 30, 2026 | Trimmed | 2600057D — Novo Nordisk A/S | Units/share: 0.001295 → 0.001236 (-4.6%) |
| Sept. 30, 2026 | Trimmed | 2645588D — Eli Lilly & Co | Units/share: 0.002165 → 0.002066 (-4.6%) |
| Sept. 30, 2026 | Trimmed | 2673120D — Esperion Therapeutics Inc | Units/share: 0.004514 → 0.004308 (-4.6%) |
| Sept. 30, 2026 | Increased | AARD — Aardvark Therapeutics Inc | Units/share: 0.0004962 → 0.0004967 (0.1%) |
| Sept. 30, 2026 | Increased | ABSI — Absci Corp | Units/share: 0.003953 → 0.003958 (0.1%) |
| Sept. 30, 2026 | Trimmed | ABVX — Abivax SA | Units/share: 0.001317 → 0.001315 (-0.1%) |
| Sept. 30, 2026 | Trimmed | ACIU — AC Immune SA | Units/share: 0.002344 → 0.00234 (-0.2%) |
| Sept. 30, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.007675 → 0.01118 (45.6%) |
| Sept. 30, 2026 | Increased | ANAB — AnaptysBio Inc | Units/share: 0.0006843 → 0.000685 (0.1%) |
| Sept. 30, 2026 | Trimmed | ANIP — ANI Pharmaceuticals Inc | Units/share: 0.0005259 → 0.0005248 (-0.2%) |
| Sept. 30, 2026 | Increased | ARCT — Arcturus Therapeutics Holdings Inc | Units/share: 0.0006625 → 0.0006642 (0.3%) |
| Sept. 30, 2026 | Trimmed | ARGX — Argenx SE | Units/share: 0.0006287 → 0.0006274 (-0.2%) |
| Sept. 30, 2026 | Increased | ARWR — Arrowhead Pharmaceuticals Inc | Units/share: 0.003254 → 0.003258 (0.1%) |
| Sept. 30, 2026 | Increased | AUPH — Aurinia Pharmaceuticals Inc | Units/share: 0.003065 → 0.003068 (0.1%) |
| Sept. 30, 2026 | Trimmed | AVBP — ArriVent Biopharma Inc | Units/share: 0.001134 → 0.001133 (-0.1%) |
| Sept. 30, 2026 | Increased | AVIR — Atea Pharmaceuticals Inc | Units/share: 0.001878 → 0.00188 (0.1%) |
| Sept. 30, 2026 | Trimmed | AVXL — Anavex Life Sciences Corp | Units/share: 0.002135 → 0.002132 (-0.2%) |
| Sept. 30, 2026 | Increased | BCYC — Bicycle Therapeutics PLC | Units/share: 0.001069 → 0.00107 (0.1%) |
| Sept. 30, 2026 | Increased | BNTX — BioNTech SE | Units/share: 0.002667 → 0.00267 (0.1%) |
| Sept. 30, 2026 | Trimmed | CCCC — C4 Therapeutics Inc | Units/share: 0.002834 → 0.002831 (-0.1%) |
| Sept. 30, 2026 | Increased | CGEM — Cullinan Therapeutics Inc | Units/share: 0.001482 → 0.001484 (0.1%) |
| Sept. 30, 2026 | Increased | CHRS — Coherus Oncology Inc | Units/share: 0.003559 → 0.003563 (0.1%) |
| Sept. 30, 2026 | Increased | COLL — Collegium Pharmaceutical Inc | Units/share: 0.0007556 → 0.0007577 (0.3%) |
| Sept. 30, 2026 | Trimmed | CRSP — CRISPR Therapeutics AG | Units/share: 0.002227 → 0.002225 (-0.1%) |
| Sept. 30, 2026 | Increased | CRVS — Corvus Pharmaceuticals Inc | Units/share: 0.001956 → 0.001958 (0.1%) |
| Sept. 30, 2026 | Trimmed | CSTL — Castle Biosciences Inc | Units/share: 0.0007083 → 0.0007075 (-0.1%) |
| Sept. 30, 2026 | Increased | CTNM — Contineum Therapeutics Inc | Units/share: 0.0007618 → 0.0007635 (0.2%) |
| Sept. 30, 2026 | Increased | DSGN — Design Therapeutics Inc | Units/share: 0.001455 → 0.001457 (0.1%) |
| Sept. 30, 2026 | Increased | ENTA — Enanta Pharmaceuticals Inc | Units/share: 0.0006724 → 0.0006736 (0.2%) |
| Sept. 30, 2026 | Trimmed | EOLS — Evolus Inc | Units/share: 0.001536 → 0.001534 (-0.1%) |
| Sept. 30, 2026 | Increased | ETON — Eton Pharmaceuticals Inc | Units/share: 0.0006604 → 0.0006622 (0.3%) |
| Sept. 30, 2026 | Trimmed | EYPT — EyePoint Inc | Units/share: 0.001946 → 0.001944 (-0.1%) |
| Sept. 30, 2026 | Increased | FDMT — 4D Molecular Therapeutics Inc | Units/share: 0.001253 → 0.001255 (0.2%) |
| Sept. 30, 2026 | Increased | FHTX — Foghorn Therapeutics Inc | Units/share: 0.00137 → 0.001371 (0.1%) |
| Sept. 30, 2026 | Increased | FULC — Fulcrum Therapeutics Inc | Units/share: 0.00176 → 0.001762 (0.1%) |
| Sept. 30, 2026 | Increased | GHRS — GH Research PLC | Units/share: 0.001581 → 0.001583 (0.1%) |
| Sept. 30, 2026 | Trimmed | GMAB — Genmab A/S | Units/share: 0.002233 → 0.00223 (-0.1%) |
| Sept. 30, 2026 | Trimmed | GOSS — Gossamer Bio Inc | Units/share: 0.0001386 → 0.0001368 (-1.3%) |
| Sept. 30, 2026 | Trimmed | GRAL — GRAIL Inc | Units/share: 0.001027 → 0.001026 (-0.1%) |
| Sept. 30, 2026 | Trimmed | HRMY — Harmony Biosciences Holdings Inc | Units/share: 0.001344 → 0.001342 (-0.1%) |
| Sept. 30, 2026 | Increased | HROW — Harrow Inc | Units/share: 0.0008655 → 0.0008671 (0.2%) |
| Sept. 30, 2026 | Increased | IMCR — Immunocore Holdings PLC | Units/share: 0.001069 → 0.00107 (0.1%) |
| Sept. 30, 2026 | Trimmed | INBX — Inhibrx Biosciences Inc | Units/share: 0.0003392 → 0.0003375 (-0.5%) |
| Sept. 30, 2026 | Increased | IRON — Disc Medicine Inc | Units/share: 0.0008873 → 0.0008886 (0.1%) |
| Sept. 30, 2026 | Trimmed | JANX — Janux Therapeutics Inc | Units/share: 0.001419 → 0.001417 (-0.1%) |
| Sept. 30, 2026 | Increased | KMDA — Kamada Ltd | Units/share: 0.001355 → 0.001357 (0.2%) |
| Sept. 30, 2026 | Trimmed | KNSA — Kiniksa Pharmaceuticals International Plc | Units/share: 0.001112 → 0.001111 (-0.1%) |
| Sept. 30, 2026 | Trimmed | KOD — Kodiak Sciences Inc | Units/share: 0.001443 → 0.001441 (-0.1%) |
| Sept. 30, 2026 | Increased | KROS — Keros Therapeutics Inc | Units/share: 0.0004621 → 0.0004638 (0.4%) |
| Sept. 30, 2026 | Increased | KRYS — Krystal Biotech Inc | Units/share: 0.0006826 → 0.0006834 (0.1%) |
| Sept. 30, 2026 | Trimmed | LENZ — LENZ Therapeutics Inc | Units/share: 0.0007102 → 0.0007091 (-0.1%) |
| Sept. 30, 2026 | Increased | LFCR — Lifecore Biomedical Inc | Units/share: 0.0008631 → 0.0008648 (0.2%) |
| Sept. 30, 2026 | Increased | LGND — Ligand Pharmaceuticals Inc | Units/share: 0.0004614 → 0.0004632 (0.4%) |
| Sept. 30, 2026 | Increased | LKFT — Lakefront Biotherapeutics NV | Units/share: 0.0003529 → 0.000355 (0.6%) |
| Sept. 30, 2026 | Increased | LXEO — Lexeo Therapeutics Inc | Units/share: 0.001858 → 0.00186 (0.1%) |
| Sept. 30, 2026 | Trimmed | LYEL — Lyell Immunopharma Inc | Units/share: 0.0005474 → 0.0005453 (-0.4%) |
| Sept. 30, 2026 | Trimmed | MDGL — Madrigal Pharmaceuticals Inc | Units/share: 0.0005328 → 0.0005313 (-0.3%) |
| Sept. 30, 2026 | Trimmed | MEDP — Medpace Holdings Inc | Units/share: 0.0006433 → 0.0006414 (-0.3%) |
| Sept. 30, 2026 | Trimmed | MENS — Jyong Biotech Ltd | Units/share: 0.001723 → 0.001721 (-0.1%) |
| Sept. 30, 2026 | Trimmed | MESO — Mesoblast Ltd | Units/share: 0.001222 → 0.00122 (-0.2%) |
| Sept. 30, 2026 | Trimmed | MLYS — Mineralys Therapeutics Inc | Units/share: 0.002036 → 0.002033 (-0.2%) |
| Sept. 30, 2026 | Trimmed | MRVI — Maravai LifeSciences Holdings Inc | Units/share: 0.003439 → 0.003435 (-0.1%) |
| Sept. 30, 2026 | Increased | NAMS — Newamsterdam Pharma Co NV | Units/share: 0.002754 → 0.002758 (0.2%) |
| Sept. 30, 2026 | Increased | NBP — NovaBridge Biosciences | Units/share: 0.00256 → 0.002564 (0.2%) |
| Sept. 30, 2026 | Increased | NGNE — Neurogene Inc | Units/share: 0.0004628 → 0.0004645 (0.4%) |
| Sept. 30, 2026 | Trimmed | NTLA — Intellia Therapeutics Inc | Units/share: 0.003245 → 0.00324 (-0.1%) |
| Sept. 30, 2026 | Increased | OABI — OmniAb Inc | Units/share: 0.003366 → 0.00337 (0.1%) |
| Sept. 30, 2026 | Increased | OBIO — Orchestra BioMed Holdings Inc | Units/share: 0.001385 → 0.001386 (0.1%) |
| Sept. 30, 2026 | Increased | OMER — Omeros Corp | Units/share: 0.001668 → 0.001671 (0.2%) |
| Sept. 30, 2026 | Trimmed | ONC — BeOne Medicines Ltd | Units/share: 0.0008266 → 0.0008254 (-0.1%) |
| Sept. 30, 2026 | Trimmed | ORKA — Oruka Therapeutics Inc | Units/share: 0.001525 → 0.001523 (-0.2%) |
| Sept. 30, 2026 | Increased | PAHC — Phibro Animal Health Corp | Units/share: 0.000487 → 0.0004876 (0.1%) |
| Sept. 30, 2026 | Increased | PBYI — Puma Biotechnology Inc | Units/share: 0.001184 → 0.001186 (0.1%) |
| Sept. 30, 2026 | Trimmed | PCRX — Pacira BioSciences Inc | Units/share: 0.0009165 → 0.000915 (-0.2%) |
| Sept. 30, 2026 | Increased | PHAT — Phathom Pharmaceuticals Inc | Units/share: 0.001867 → 0.00187 (0.2%) |
| Sept. 30, 2026 | Trimmed | PHVS — Pharvaris NV | Units/share: 0.001622 → 0.00162 (-0.1%) |
| Sept. 30, 2026 | Trimmed | PRAX — Praxis Precision Medicines Inc | Units/share: 0.0006433 → 0.0006414 (-0.3%) |
| Sept. 30, 2026 | Increased | PRTA — Prothena Corp PLC | Units/share: 0.001183 → 0.001184 (0.1%) |
| Sept. 30, 2026 | Increased | PSNL — Personalis Inc | Units/share: 0.00246 → 0.002464 (0.2%) |
| Sept. 30, 2026 | Trimmed | PTCT — PTC Therapeutics Inc | Units/share: 0.001921 → 0.001919 (-0.1%) |
| Sept. 30, 2026 | Trimmed | PYXS — Pyxis Oncology Inc | Units/share: 0.001921 → 0.001919 (-0.1%) |
| Sept. 30, 2026 | Increased | RANI — Rani Therapeutics Holdings Inc | Units/share: 0.002563 → 0.002566 (0.2%) |
| Sept. 30, 2026 | Increased | RARE — Ultragenyx Pharmaceutical Inc | Units/share: 0.002262 → 0.002266 (0.2%) |
| Sept. 30, 2026 | Trimmed | RCKT — Rocket Pharmaceuticals Inc | Units/share: 0.002529 → 0.002526 (-0.1%) |
| Sept. 30, 2026 | Increased | REPL — Replimune Group Inc | Units/share: 0.002171 → 0.002173 (0.1%) |
| Sept. 30, 2026 | Trimmed | RGNX — REGENXBIO Inc | Units/share: 0.001521 → 0.001519 (-0.1%) |
| Sept. 30, 2026 | Trimmed | RIGL — Rigel Pharmaceuticals Inc | Units/share: 0.0004276 → 0.0004264 (-0.3%) |
| Sept. 30, 2026 | Trimmed | SGMT — Sagimet Biosciences Inc | Units/share: 0.001427 → 0.001424 (-0.2%) |
| Sept. 30, 2026 | Increased | SIGA — SIGA Technologies Inc | Units/share: 0.001657 → 0.001659 (0.1%) |
| Sept. 30, 2026 | Trimmed | SION — Sionna Therapeutics Inc | Units/share: 0.001039 → 0.001037 (-0.2%) |
| Sept. 30, 2026 | Increased | SLDB — Solid Biosciences Inc | Units/share: 0.00247 → 0.002473 (0.1%) |
| Sept. 30, 2026 | Trimmed | SRPT — Sarepta Therapeutics Inc | Units/share: 0.002433 → 0.00243 (-0.1%) |
| Sept. 30, 2026 | Trimmed | SUPN — Supernus Pharmaceuticals Inc | Units/share: 0.001337 → 0.001335 (-0.1%) |
| Sept. 30, 2026 | Trimmed | SYRE — Spyre Therapeutics Inc | Units/share: 0.002031 → 0.002028 (-0.1%) |
| Sept. 30, 2026 | Increased | TARS — Tarsus Pharmaceuticals Inc | Units/share: 0.001061 → 0.001063 (0.2%) |
| Sept. 30, 2026 | Trimmed | TECX — Tectonic Therapeutic Inc | Units/share: 0.0004379 → 0.0004362 (-0.4%) |
| Sept. 30, 2026 | Trimmed | THRD — Third Harmonic Bio Inc | Units/share: 0.0005478 → 0.0005228 (-4.6%) |
| Sept. 30, 2026 | Trimmed | TKNO — Alpha Teknova Inc | Units/share: 0.001235 → 0.001233 (-0.1%) |
| Sept. 30, 2026 | Trimmed | TRAX — First Tracks Biotherapeutics Inc | Units/share: 0.0008218 → 0.0008208 (-0.1%) |
| Sept. 30, 2026 | Increased | TVTX — Travere Therapeutics Inc | Units/share: 0.002171 → 0.002174 (0.1%) |
| Sept. 30, 2026 | Increased | TXG — 10X Genomics Inc | Units/share: 0.002769 → 0.002772 (0.1%) |
| Sept. 30, 2026 | Increased | UPB — Upstream Bio Inc | Units/share: 0.001263 → 0.001265 (0.1%) |
| Sept. 30, 2026 | Trimmed | URGN — UroGen Pharma Ltd | Units/share: 0.001129 → 0.001128 (-0.1%) |
| Sept. 30, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.003116 → 0.003007 (-3.5%) |
| Sept. 30, 2026 | Increased | UTHR — United Therapeutics Corp | Units/share: 0.0009881 → 0.0009893 (0.1%) |
| Sept. 30, 2026 | Increased | VCYT — Veracyte Inc | Units/share: 0.001856 → 0.001858 (0.1%) |
| Sept. 30, 2026 | Increased | VERA — Vera Therapeutics Inc | Units/share: 0.001662 → 0.001664 (0.1%) |
| Sept. 30, 2026 | Increased | VOR — Vor BioPharma Inc | Units/share: 0.001365 → 0.001366 (0.1%) |
| Sept. 30, 2026 | Trimmed | XENE — Xenon Pharmaceuticals Inc | Units/share: 0.002231 → 0.002228 (-0.1%) |
| Sept. 30, 2026 | Trimmed | ZLAB — Zai Lab Ltd | Units/share: 0.001025 → 0.001024 (-0.1%) |
| Sept. 30, 2026 | Increased | ZVRA — Zevra Therapeutics Inc | Units/share: 0.00137 → 0.001371 (0.1%) |
| Sept. 30, 2026 | Trimmed | — SECURITIES LENDING - BNYM | Units/share: 0.0000003413 → 0.0000003257 (-4.6%) |
| Sept. 29, 2026 | New | AGPXX — Invesco Government & Agency Portfolio | New position — 0.007675 units/share |
| Sept. 29, 2026 | Increased | USD — CASH & EQUIVALENTS | Units/share: -0.003317 → 0.003116 (-193.9%) |
| Sept. 25, 2026 | Exited | AGPXX — Invesco Government & Agency Portfolio | Position exited — was 0.2121 units/share |
| Sept. 25, 2026 | Trimmed | USD — CASH & EQUIVALENTS | Units/share: 0.003116 → -0.003317 (-206.5%) |
| Sept. 24, 2026 | Increased | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.2115 → 0.2121 (0.3%) |
| Sept. 24, 2026 | Increased | ARGX — Argenx SE | Units/share: 0.000627 → 0.0006287 (0.3%) |
| Sept. 24, 2026 | Increased | INBX — Inhibrx Biosciences Inc | Units/share: 0.0003358 → 0.0003392 (1.0%) |
| Sept. 24, 2026 | Increased | MDGL — Madrigal Pharmaceuticals Inc | Units/share: 0.0005307 → 0.0005328 (0.4%) |
| Sept. 24, 2026 | Increased | MEDP — Medpace Holdings Inc | Units/share: 0.0006406 → 0.0006433 (0.4%) |
| Sept. 24, 2026 | Increased | NBIX — Neurocrine Biosciences Inc | Units/share: 0.002341 → 0.002344 (0.1%) |
| Sept. 24, 2026 | Increased | ONC — BeOne Medicines Ltd | Units/share: 0.0008246 → 0.0008266 (0.2%) |
| Sept. 24, 2026 | Increased | PRAX — Praxis Precision Medicines Inc | Units/share: 0.000641 → 0.0006433 (0.4%) |
| Sept. 24, 2026 | Exited | TBPH | Position exited — was 0.001196 units/share |
| Sept. 23, 2026 | Trimmed | 2200963D — OmniAb Inc | Units/share: 0.00004496 → 0.00004266 (-5.1%) |
| Sept. 23, 2026 | Trimmed | 2200964D — OmniAb Inc | Units/share: 0.00004496 → 0.00004266 (-5.1%) |
| Sept. 23, 2026 | Trimmed | 2324462D — Cartesian Therapeutics Inc | Units/share: 0.0009471 → 0.0008986 (-5.1%) |
| Sept. 23, 2026 | Trimmed | 2600057D — Novo Nordisk A/S | Units/share: 0.001365 → 0.001295 (-5.1%) |
| Sept. 23, 2026 | Trimmed | 2645588D — Eli Lilly & Co | Units/share: 0.002282 → 0.002165 (-5.1%) |
| Sept. 23, 2026 | Trimmed | 2673120D — Esperion Therapeutics Inc | Units/share: 0.004757 → 0.004514 (-5.1%) |
| Sept. 23, 2026 | Increased | AGIO — Agios Pharmaceuticals Inc | Units/share: 0.001372 → 0.001373 (0.1%) |
| Sept. 23, 2026 | Trimmed | AGPXX — Invesco Government & Agency Portfolio | Units/share: 0.2171 → 0.2115 (-2.6%) |
| Sept. 23, 2026 | Increased | AMPH — Amphastar Pharmaceuticals Inc | Units/share: 0.0009799 → 0.0009809 (0.1%) |
| Sept. 23, 2026 | Increased | ANAB — AnaptysBio Inc | Units/share: 0.0006835 → 0.0006843 (0.1%) |
| Sept. 23, 2026 | Trimmed | ANIP — ANI Pharmaceuticals Inc | Units/share: 0.0005276 → 0.0005259 (-0.3%) |
| Sept. 23, 2026 | Increased | ARCT — Arcturus Therapeutics Holdings Inc | Units/share: 0.0006604 → 0.0006625 (0.3%) |
| Sept. 23, 2026 | Trimmed | ARGX — Argenx SE | Units/share: 0.0006284 → 0.000627 (-0.2%) |
| Sept. 23, 2026 | Trimmed | AVBP — ArriVent Biopharma Inc | Units/share: 0.001136 → 0.001134 (-0.2%) |
| Sept. 23, 2026 | Trimmed | BCAX — Bicara Therapeutics Inc | Units/share: 0.001526 → 0.001524 (-0.1%) |
| Sept. 23, 2026 | Increased | BCYC — Bicycle Therapeutics PLC | Units/share: 0.001066 → 0.001069 (0.2%) |
| Sept. 23, 2026 | Increased | BIOA — BioAge Labs Inc | Units/share: 0.001077 → 0.001078 (0.1%) |
| Sept. 23, 2026 | Increased | CADL — Candel Therapeutics Inc | Units/share: 0.001763 → 0.001765 (0.1%) |
| Sept. 23, 2026 | Trimmed | CGON — CG oncology Inc | Units/share: 0.002042 → 0.00204 (-0.1%) |
| Sept. 23, 2026 | Increased | COLL — Collegium Pharmaceutical Inc | Units/share: 0.0007527 → 0.0007556 (0.4%) |
| Sept. 23, 2026 | Increased | CRBU — Caribou Biosciences Inc | Units/share: 0.002262 → 0.002265 (0.1%) |
| Sept. 23, 2026 | Increased | CRVS — Corvus Pharmaceuticals Inc | Units/share: 0.001953 → 0.001956 (0.1%) |
| Sept. 23, 2026 | Increased | CTNM — Contineum Therapeutics Inc | Units/share: 0.0007597 → 0.0007618 (0.3%) |
| Sept. 23, 2026 | Increased | DSGN — Design Therapeutics Inc | Units/share: 0.001453 → 0.001455 (0.2%) |
| Sept. 23, 2026 | Increased | ENTA — Enanta Pharmaceuticals Inc | Units/share: 0.0006709 → 0.0006724 (0.2%) |
| Sept. 23, 2026 | Trimmed | EOLS — Evolus Inc | Units/share: 0.001538 → 0.001536 (-0.1%) |
| Sept. 23, 2026 | Increased | ETON — Eton Pharmaceuticals Inc | Units/share: 0.0006583 → 0.0006604 (0.3%) |
| Sept. 23, 2026 | Trimmed | EYPT — EyePoint Inc | Units/share: 0.001948 → 0.001946 (-0.1%) |
| Sept. 23, 2026 | Increased | FDMT — 4D Molecular Therapeutics Inc | Units/share: 0.001251 → 0.001253 (0.2%) |
| Sept. 23, 2026 | Increased | FHTX — Foghorn Therapeutics Inc | Units/share: 0.001368 → 0.00137 (0.1%) |
| Sept. 23, 2026 | Increased | FULC — Fulcrum Therapeutics Inc | Units/share: 0.001758 → 0.00176 (0.1%) |
| Sept. 23, 2026 | Increased | GLUE — Monte Rosa Therapeutics Inc | Units/share: 0.001961 → 0.001964 (0.1%) |
| Sept. 23, 2026 | Trimmed | GOSS — Gossamer Bio Inc | Units/share: 0.0001406 → 0.0001386 (-1.5%) |
| Sept. 23, 2026 | Trimmed | GRAL — GRAIL Inc | Units/share: 0.001029 → 0.001027 (-0.1%) |
| Sept. 23, 2026 | Trimmed | HRMY — Harmony Biosciences Holdings Inc | Units/share: 0.001346 → 0.001344 (-0.2%) |
| Sept. 23, 2026 | Increased | HROW — Harrow Inc | Units/share: 0.0008637 → 0.0008655 (0.2%) |
| Sept. 23, 2026 | Increased | IMCR — Immunocore Holdings PLC | Units/share: 0.001067 → 0.001069 (0.2%) |
| Sept. 23, 2026 | Trimmed | INBX — Inhibrx Biosciences Inc | Units/share: 0.0003378 → 0.0003358 (-0.6%) |
| Sept. 23, 2026 | Increased | INVA — Innoviva Inc | Units/share: 0.001664 → 0.001666 (0.1%) |
| Sept. 23, 2026 | Increased | KMDA — Kamada Ltd | Units/share: 0.001352 → 0.001355 (0.2%) |
| Sept. 23, 2026 | Trimmed | KOD — Kodiak Sciences Inc | Units/share: 0.001445 → 0.001443 (-0.2%) |
| Sept. 23, 2026 | Increased | KROS — Keros Therapeutics Inc | Units/share: 0.0004596 → 0.0004621 (0.5%) |
| Sept. 23, 2026 | Increased | KRYS — Krystal Biotech Inc | Units/share: 0.0006817 → 0.0006826 (0.1%) |
| Sept. 23, 2026 | Increased | KURA — Kura Oncology Inc | Units/share: 0.002061 → 0.002063 (0.1%) |
| Sept. 23, 2026 | Trimmed | KYTX — Kyverna Therapeutics Inc | Units/share: 0.001429 → 0.001428 (-0.1%) |
| Sept. 23, 2026 | Increased | LFCR — Lifecore Biomedical Inc | Units/share: 0.0008612 → 0.0008631 (0.2%) |
| Sept. 23, 2026 | Increased | LGND — Ligand Pharmaceuticals Inc | Units/share: 0.0004594 → 0.0004614 (0.5%) |
| Sept. 23, 2026 | Increased | LKFT — Lakefront Biotherapeutics NV | Units/share: 0.0003504 → 0.0003529 (0.7%) |
| Sept. 23, 2026 | Increased | LXEO — Lexeo Therapeutics Inc | Units/share: 0.001856 → 0.001858 (0.1%) |
| Sept. 23, 2026 | Trimmed | LYEL — Lyell Immunopharma Inc | Units/share: 0.00055 → 0.0005474 (-0.5%) |
| Sept. 23, 2026 | Increased | MAZE — Maze Therapeutics Inc | Units/share: 0.001274 → 0.001275 (0.1%) |
| Sept. 23, 2026 | Trimmed | MDGL — Madrigal Pharmaceuticals Inc | Units/share: 0.0005324 → 0.0005307 (-0.3%) |
| Sept. 23, 2026 | Trimmed | MEDP — Medpace Holdings Inc | Units/share: 0.0006428 → 0.0006406 (-0.3%) |
| Sept. 23, 2026 | Increased | NGNE — Neurogene Inc | Units/share: 0.0004608 → 0.0004628 (0.4%) |
| Sept. 23, 2026 | Trimmed | ONC — BeOne Medicines Ltd | Units/share: 0.0008259 → 0.0008246 (-0.2%) |
| Sept. 23, 2026 | Increased | PAHC — Phibro Animal Health Corp | Units/share: 0.0004863 → 0.000487 (0.1%) |
| Sept. 23, 2026 | Trimmed | PRAX — Praxis Precision Medicines Inc | Units/share: 0.0006432 → 0.000641 (-0.3%) |
| Sept. 23, 2026 | Trimmed | RIGL — Rigel Pharmaceuticals Inc | Units/share: 0.0004295 → 0.0004276 (-0.4%) |
| Sept. 23, 2026 | Increased | SEPN — Septerna Inc | Units/share: 0.001075 → 0.001076 (0.1%) |
| Sept. 23, 2026 | Increased | SIGA — SIGA Technologies Inc | Units/share: 0.001655 → 0.001657 (0.1%) |
| Sept. 23, 2026 | Trimmed | SION — Sionna Therapeutics Inc | Units/share: 0.001041 → 0.001039 (-0.2%) |
| Sept. 23, 2026 | Increased | SNDX — Syndax Pharmaceuticals Inc | Units/share: 0.002057 → 0.00206 (0.1%) |
| Sept. 23, 2026 | Trimmed | SUPN — Supernus Pharmaceuticals Inc | Units/share: 0.001339 → 0.001337 (-0.1%) |
| Sept. 23, 2026 | Increased | TARS — Tarsus Pharmaceuticals Inc | Units/share: 0.001059 → 0.001061 (0.2%) |
| Sept. 23, 2026 | Trimmed | TECX — Tectonic Therapeutic Inc | Units/share: 0.0004399 → 0.0004379 (-0.5%) |
| Sept. 23, 2026 | Trimmed | THRD — Third Harmonic Bio Inc | Units/share: 0.0005773 → 0.0005478 (-5.1%) |
| Sept. 23, 2026 | Trimmed | TKNO — Alpha Teknova Inc | Units/share: 0.001237 → 0.001235 (-0.2%) |
| Sept. 23, 2026 | Trimmed | TRAX — First Tracks Biotherapeutics Inc | Units/share: 0.000823 → 0.0008218 (-0.1%) |
| Sept. 23, 2026 | Increased | TYRA — Tyra Biosciences Inc | Units/share: 0.00137 → 0.001371 (0.1%) |
| Sept. 23, 2026 | Increased | UPB — Upstream Bio Inc | Units/share: 0.001262 → 0.001263 (0.2%) |
| Sept. 23, 2026 | Trimmed | URGN — UroGen Pharma Ltd | Units/share: 0.001131 → 0.001129 (-0.2%) |
Showing latest 200 of 773 changes
Dividends 21 payments
| Ex-date | Amount / share |
|---|---|
| Sept. 21, 2026 | $0.2300 |
| June 22, 2026 | $0.0340 |
| March 23, 2026 | $0.0360 |
| Dec. 22, 2025 | $0.0910 |
| Sept. 22, 2025 | $0.0960 |
| June 23, 2025 | $0.0290 |
| March 24, 2025 | $0.0400 |
| Dec. 23, 2024 | $0.0620 |
| Sept. 23, 2024 | $0.0890 |
| June 24, 2024 | $0.0510 |
| March 18, 2024 | $0.0440 |
| Dec. 18, 2023 | $0.0530 |
| Sept. 18, 2023 | $0.0410 |
| June 20, 2023 | $0.0450 |
| March 20, 2023 | $0.0380 |
| Dec. 19, 2022 | $0.0420 |
| Sept. 19, 2022 | $0.0380 |
| June 21, 2022 | $0.0430 |
| March 21, 2022 | $0.0380 |
| Dec. 20, 2021 | $0.1050 |
| Sept. 20, 2021 | $0.0430 |
Institutional owners (13F) 36 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| RAYMOND JAMES FINANCIAL INC | $3,115,135 | 18.63% | 95,381 | Shares | June 30, 2026 |
| WMS Group LLC | $1,930,794 | 11.55% | 59,118 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $1,678,724 | 10.04% | 51,400 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,631,404 | 9.76% | 49,951 | Shares | June 30, 2026 |
| Independent Advisor Alliance | $969,232 | 5.80% | 29,676 | Shares | June 30, 2026 |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | $956,938 | 5.72% | 29,300 | Shares | June 30, 2026 |
| Advisory Services Network, LLC | $710,638 | 4.25% | 21,759 | Shares | June 30, 2026 |
| Churchill Financial Advisors, LLC | $663,847 | 3.97% | 20,326 | Shares | June 30, 2026 |
| Orion Porfolio Solutions, LLC | $646,333 | 3.87% | 19,790 | Shares | June 30, 2026 |
| Clearstead Advisors, LLC | $634,959 | 3.80% | 19,441 | Shares | June 30, 2026 |
| LPL Financial LLC | $521,254 | 3.12% | 15,960 | Shares | June 30, 2026 |
| Tower Research Capital LLC (TRC) | $496,236 | 2.97% | 15,194 | Shares | June 30, 2026 |
| Concurrent Investment Advisors, LLC | $463,849 | 2.77% | 14,202 | Shares | June 30, 2026 |
| Clarius Group, LLC | $407,512 | 2.44% | 19,231 | Shares | March 31, 2025 |
| Beckerman Institutional, LLC | $374,138 | 2.24% | 11,456 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $346,564 | 2.07% | 10,611 | Shares | June 30, 2026 |
| CreativeOne Wealth, LLC | $289,470 | 1.73% | 8,863 | Shares | June 30, 2026 |
| Ignite Planners, LLC | $260,267 | 1.56% | 7,954 | Shares | June 30, 2026 |
| Breakwater Capital Group | $230,678 | 1.38% | 7,063 | Shares | June 30, 2026 |
| Lauer Wealth, LLC | $201,252 | 1.20% | 6,200 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $43,000 | 0.26% | 1,306 | Shares | June 30, 2026 |
| ORG Partners LLC | $30,298 | 0.18% | 1,067 | Shares | Dec. 31, 2025 |
| Signature Equity Partners, LLC | $21,345 | 0.13% | 654 | Shares | June 30, 2026 |
| Princeton Global Asset Management LLC | $19,617 | 0.12% | 601 | Shares | June 30, 2026 |
| MORGAN STANLEY | $18,001 | 0.11% | 551 | Shares | June 30, 2026 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $16,330 | 0.10% | 500 | Shares | June 30, 2026 |
| FMR LLC | $8,590 | 0.05% | 263 | Shares | June 30, 2026 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $8,197 | 0.05% | 251 | Shares | June 30, 2026 |
| PRIVATE TRUST CO NA | $7,414 | 0.04% | 227 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $5,467 | 0.03% | 167 | Shares | June 30, 2026 |
| Strengthening Families & Communities, LLC | $3,218 | 0.02% | 99 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $2,776 | 0.02% | 85 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $2,515 | 0.02% | 77 | Shares | June 30, 2026 |
| AE Wealth Management LLC | $2,188 | 0.01% | 67 | Shares | June 30, 2026 |
| Meramec Financial Planners, LLC | $815 | 0.00% | 25 | Shares | June 30, 2026 |
| Farmers & Merchants Trust Co of Chambersburg PA | $7 | 0.00% | 200 | Shares | June 30, 2026 |